VMD vs. FTRE, PNTG, CDNA, CSTL, FLGT, AGL, INNV, AUNA, TALK, and PSNL
Should you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include Fortrea (FTRE), The Pennant Group (PNTG), CareDx (CDNA), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Agilon Health (AGL), InnovAge (INNV), Auna (AUNA), Talkspace (TALK), and Personalis (PSNL). These companies are all part of the "healthcare" industry.
Viemed Healthcare vs. Its Competitors
Fortrea (NASDAQ:FTRE) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.
Fortrea currently has a consensus price target of $12.78, suggesting a potential upside of 9.87%. Given Fortrea's stronger consensus rating and higher probable upside, research analysts clearly believe Fortrea is more favorable than Viemed Healthcare.
74.2% of Viemed Healthcare shares are owned by institutional investors. 0.4% of Fortrea shares are owned by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Fortrea has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500.
Viemed Healthcare has a net margin of 5.80% compared to Fortrea's net margin of -37.57%. Viemed Healthcare's return on equity of 10.38% beat Fortrea's return on equity.
In the previous week, Fortrea had 11 more articles in the media than Viemed Healthcare. MarketBeat recorded 14 mentions for Fortrea and 3 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.66 beat Fortrea's score of 1.30 indicating that Viemed Healthcare is being referred to more favorably in the news media.
Viemed Healthcare has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
Summary
Viemed Healthcare beats Fortrea on 10 of the 17 factors compared between the two stocks.
Get Viemed Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding VMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Viemed Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:VMD) was last updated on 9/5/2025 by MarketBeat.com Staff
Free VMD Stock Alerts